methadone has been researched along with Tuberculosis in 20 studies
Methadone: A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3)
methadone : A racemate comprising equimolar amounts of dextromethadone and levomethadone. It is a opioid analgesic which is used as a painkiller and as a substitute for heroin in the treatment of heroin addiction.
6-(dimethylamino)-4,4-diphenylheptan-3-one : A ketone that is heptan-3-one substituted by a dimethylamino group at position 6 and two phenyl groups at position 4.
Tuberculosis: Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate an approach to enhancing compliance with tuberculosis chemoprophylaxis in drug users enrolled on methadone maintenance utilizing an isoniazid (INH)-methadone admixture." | 7.70 | Tuberculosis chemoprophylaxis using a liquid isoniazid-methadone admixture for drug users in methadone maintenance. ( Durante, AJ; Friedman, L; Henry, S; O'Connor, PG; Selwyn, PA; Shi, JM, 1999) |
| "The rate of tuberculosis in patients receiving methadone treatment is significantly greater than the general population." | 7.69 | Tuberculosis treatment through directly observed therapy in a large multisite methadone maintenance treatment program: addressing the public health needs of a high-risk population. ( Altarac, D; Dansky, SF, 1995) |
| " This study compared completion rates for isoniazid (INH) preventive therapy for injection drug users (IDUs) randomly assigned to methadone treatment combined with directly observed preventive treatment (DOPT) versus those assigned to routine TB clinic referral without methadone treatment." | 6.70 | A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users. ( Batki, SL; Bradley, JM; Bradley, M; Delucchi, K; Gruber, VA, 2002) |
| "Methadone maintenance treatment (MMT) has been available in Guangdong province, China since 2006." | 5.39 | High prevalence of HIV, HCV and tuberculosis and associated risk behaviours among new entrants of methadone maintenance treatment clinics in Guangdong Province, China. ( Chen, W; Ling, L; Zhang, D; Zhang, L; Zou, X, 2013) |
| "Treatment with isoniazid was beneficial in HIV-infected, tuberculin-positive IDUs." | 5.32 | Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programs. ( Amofa, J; Driver, CR; Fujiwara, PI; Gourevitch, MN; Highley, E; Kaye, K; Munsiff, SS; Rubino, MA; Scholten, JN; Seewald, R; Trim, C, 2003) |
| "Methadone dosing was not contingent upon ingestion of antituberculous medication(s)." | 5.29 | Successful adherence to observed prophylaxis and treatment of tuberculosis among drug users in a methadone program. ( Gourevitch, MN; Panero, MS; Selwyn, PA; Wasserman, W, 1996) |
| "To analyse prevalence of hidden hepatitis B infection (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and tuberculosis infection in drug users (DU) in a maintenance programme with methadone (MPM)." | 3.71 | [Prevalence of chronic hidden infections in a cohort of patients in substitutive treatment with methadone]. ( Belda, J; de Estudio Protocolo-INH, G; Esteban, J; Isabel Manso, M; Llinares, R; Portilla, J; Sánchez-Payá, J, 2001) |
| "To evaluate an approach to enhancing compliance with tuberculosis chemoprophylaxis in drug users enrolled on methadone maintenance utilizing an isoniazid (INH)-methadone admixture." | 3.70 | Tuberculosis chemoprophylaxis using a liquid isoniazid-methadone admixture for drug users in methadone maintenance. ( Durante, AJ; Friedman, L; Henry, S; O'Connor, PG; Selwyn, PA; Shi, JM, 1999) |
| "The rate of tuberculosis in patients receiving methadone treatment is significantly greater than the general population." | 3.69 | Tuberculosis treatment through directly observed therapy in a large multisite methadone maintenance treatment program: addressing the public health needs of a high-risk population. ( Altarac, D; Dansky, SF, 1995) |
| " This study compared completion rates for isoniazid (INH) preventive therapy for injection drug users (IDUs) randomly assigned to methadone treatment combined with directly observed preventive treatment (DOPT) versus those assigned to routine TB clinic referral without methadone treatment." | 2.70 | A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users. ( Batki, SL; Bradley, JM; Bradley, M; Delucchi, K; Gruber, VA, 2002) |
| "Most methadone treatment programs have insufficient resources to provide medical care." | 2.67 | Providing medical care to methadone clinic patients: referral vs on-site care. ( Bigelow, GE; Ginn, DH; Pabst, KM; Umbricht-Schneiter, A, 1994) |
| " The results confirm the importance of adequate OAT dosing (≥60mg of methadone, ≥8mg of buprenorphine)." | 1.46 | Retention in medication-assisted treatment programs in Ukraine-Identifying factors contributing to a continuing HIV epidemic. ( Altice, FL; Chernova, O; Dumchev, K; Dvoryak, S; Morozova, O, 2017) |
| "Methadone maintenance treatment (MMT) has been available in Guangdong province, China since 2006." | 1.39 | High prevalence of HIV, HCV and tuberculosis and associated risk behaviours among new entrants of methadone maintenance treatment clinics in Guangdong Province, China. ( Chen, W; Ling, L; Zhang, D; Zhang, L; Zou, X, 2013) |
| "Treatment with isoniazid was beneficial in HIV-infected, tuberculin-positive IDUs." | 1.32 | Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programs. ( Amofa, J; Driver, CR; Fujiwara, PI; Gourevitch, MN; Highley, E; Kaye, K; Munsiff, SS; Rubino, MA; Scholten, JN; Seewald, R; Trim, C, 2003) |
| "Methadone dosing was not contingent upon ingestion of antituberculous medication(s)." | 1.29 | Successful adherence to observed prophylaxis and treatment of tuberculosis among drug users in a methadone program. ( Gourevitch, MN; Panero, MS; Selwyn, PA; Wasserman, W, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.00) | 18.7374 |
| 1990's | 6 (30.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 6 (30.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roberts, L | 1 |
| Dumchev, K | 1 |
| Dvoryak, S | 2 |
| Chernova, O | 1 |
| Morozova, O | 2 |
| Altice, FL | 3 |
| Gowing, LR | 1 |
| Hickman, M | 1 |
| Degenhardt, L | 1 |
| Zhang, L | 1 |
| Zhang, D | 1 |
| Chen, W | 1 |
| Zou, X | 1 |
| Ling, L | 1 |
| Bruce, RD | 3 |
| Lambdin, B | 2 |
| Chang, O | 1 |
| Masao, F | 1 |
| Mbwambo, J | 2 |
| Mteza, I | 2 |
| Nyandindi, C | 2 |
| Zamudio-Haas, S | 1 |
| Buma, D | 1 |
| Dunbar, MS | 1 |
| Kilonzo, G | 1 |
| Gupta, A | 1 |
| Shenoi, S | 1 |
| Doula, BI | 1 |
| Mfaume, S | 1 |
| Schwarz, RK | 1 |
| Ball, SA | 1 |
| Herme, M | 1 |
| HEROLD, K | 1 |
| Scholten, JN | 1 |
| Driver, CR | 1 |
| Munsiff, SS | 1 |
| Kaye, K | 1 |
| Rubino, MA | 1 |
| Gourevitch, MN | 2 |
| Trim, C | 1 |
| Amofa, J | 1 |
| Seewald, R | 1 |
| Highley, E | 1 |
| Fujiwara, PI | 1 |
| Umbricht-Schneiter, A | 1 |
| Ginn, DH | 1 |
| Pabst, KM | 1 |
| Bigelow, GE | 1 |
| Sell, L | 1 |
| Finch, E | 1 |
| Farrell, M | 1 |
| Sheridan, J | 1 |
| Strang, J | 1 |
| Wasserman, W | 1 |
| Panero, MS | 1 |
| Selwyn, PA | 3 |
| Antela, A | 1 |
| Casado, JL | 1 |
| González, MJ | 1 |
| Pérez, P | 1 |
| Pérez-Elías, MJ | 1 |
| Montilla, P | 1 |
| Buzón, L | 1 |
| Altarac, D | 1 |
| Dansky, SF | 1 |
| O'Connor, PG | 1 |
| Shi, JM | 1 |
| Henry, S | 1 |
| Durante, AJ | 1 |
| Friedman, L | 1 |
| Portilla, J | 1 |
| Esteban, J | 1 |
| Llinares, R | 1 |
| Belda, J | 1 |
| Sánchez-Payá, J | 1 |
| Isabel Manso, M | 1 |
| de Estudio Protocolo-INH, G | 1 |
| Habrat, B | 1 |
| Chmielewska, K | 1 |
| Baran-Furga, H | 1 |
| Batki, SL | 1 |
| Gruber, VA | 1 |
| Bradley, JM | 1 |
| Bradley, M | 1 |
| Delucchi, K | 1 |
| Feingold, AR | 1 |
| Iezza, A | 1 |
| Satyadeo, M | 1 |
| Colley, J | 1 |
| Torres, R | 1 |
| Shaw, JF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Continuing Care Following Drug Abuse Treatment: Linkage With Primary Care[NCT01621711] | 504 participants (Actual) | Interventional | 2011-03-31 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for methadone and Tuberculosis
| Article | Year |
|---|---|
Mitigating the risk of HIV infection with opioid substitution treatment.
Topics: Antiretroviral Therapy, Highly Active; Buprenorphine; Comorbidity; Evidence-Based Medicine; Harm Red | 2013 |
2 trials available for methadone and Tuberculosis
| Article | Year |
|---|---|
Providing medical care to methadone clinic patients: referral vs on-site care.
Topics: Female; Health Services; HIV Infections; Humans; Hypertension; Male; Methadone; Referral and Consult | 1994 |
A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users.
Topics: Adult; Analysis of Variance; Antitubercular Agents; Chi-Square Distribution; Directly Observed Thera | 2002 |
17 other studies available for methadone and Tuberculosis
| Article | Year |
|---|---|
Surge of HIV, tuberculosis and COVID feared amid war in Ukraine.
Topics: Anti-HIV Agents; Armed Conflicts; COVID-19; HIV Infections; Humans; Immunization Programs; Male; Mea | 2022 |
Retention in medication-assisted treatment programs in Ukraine-Identifying factors contributing to a continuing HIV epidemic.
Topics: Adult; Buprenorphine; Cohort Studies; Delivery of Health Care, Integrated; Dose-Response Relationshi | 2017 |
High prevalence of HIV, HCV and tuberculosis and associated risk behaviours among new entrants of methadone maintenance treatment clinics in Guangdong Province, China.
Topics: Adult; Analgesics, Opioid; China; Coinfection; Comorbidity; Female; Hepatitis C; HIV Infections; Hum | 2013 |
Lessons from Tanzania on the integration of HIV and tuberculosis treatments into methadone assisted treatment.
Topics: Delivery of Health Care, Integrated; HIV Infections; Humans; Mental Health Services; Methadone; Opia | 2014 |
Methadone treatment improves tuberculosis treatment among hospitalized opioid dependent patients in Ukraine.
Topics: Adult; Analgesics, Opioid; Antitubercular Agents; Delivery of Health Care, Integrated; Drug Users; F | 2013 |
Active case finding for tuberculosis among people who inject drugs on methadone treatment in Dar es Salaam, Tanzania.
Topics: Adult; Female; Humans; Male; Methadone; Prevalence; Substance Abuse, Intravenous; Surveys and Questi | 2014 |
Comparison of tuberculin skin testing reactivity in opioid-dependent patients seeking treatment with methadone versus buprenorphine: policy implications for tuberculosis screening.
Topics: Adult; Buprenorphine; Female; Humans; Male; Methadone; Opioid-Related Disorders; Policy Making; Prev | 2009 |
[Polamidon as cough remedy in treatment of menopausal deficiencies with estrogens].
Topics: Contraceptive Agents, Female; Cough; Estradiol Congeners; Estrogens; Female; Humans; Menopause; Meth | 1953 |
Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programs.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Antitubercular Agents; Female; HIV; HIV Infectio | 2003 |
Directly observed treatment for tuberculosis. Could be provided by community pharmacists supervising consumption of methadone.
Topics: Antitubercular Agents; Community Pharmacy Services; Humans; Methadone; Patient Compliance; Substance | 1996 |
Successful adherence to observed prophylaxis and treatment of tuberculosis among drug users in a methadone program.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antitubercular Agents; Comorbidity; Female; Humans; Male; | 1996 |
Influence of a methadone maintenance programme on the improved outcome of a cohort on injecting drug users with advanced HIV disease.
Topics: Adult; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Disease Progression; Female; HIV | 1997 |
Tuberculosis treatment through directly observed therapy in a large multisite methadone maintenance treatment program: addressing the public health needs of a high-risk population.
Topics: Adult; Antitubercular Agents; Community Health Services; Female; Health Services Accessibility; Heal | 1995 |
Tuberculosis chemoprophylaxis using a liquid isoniazid-methadone admixture for drug users in methadone maintenance.
Topics: Antitubercular Agents; Cohort Studies; Drug Combinations; Female; Humans; Isoniazid; Male; Methadone | 1999 |
[Prevalence of chronic hidden infections in a cohort of patients in substitutive treatment with methadone].
Topics: Adult; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; HIV Infections; Humans; Male; Methadone; | 2001 |
[Health status of individuals dependent on opiates before and after a year of treatment in a methadone maintenance program].
Topics: Adult; Female; Health Status; Humans; Infections; Liver Diseases; Male; Methadone; Opioid-Related Di | 2001 |
Primary care for patients with human immunodeficiency virus (HIV) infection in a methadone maintenance treatment program.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aerosols; Female; HIV Infections; Humans; Male; Methadone | 1989 |